SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models

Lobos-Gonzalez, L; Aguilar-Guzmán, L; Fernandez, JG; Muñoz, N; Hossain, M; Bieneck, S; Silva, V; Burzio, V; Sviderskaya, EV; Bennett, DC; et al. Lobos-Gonzalez, L; Aguilar-Guzmán, L; Fernandez, JG; Muñoz, N; Hossain, M; Bieneck, S; Silva, V; Burzio, V; Sviderskaya, EV; Bennett, DC; Leyton, L; Quest, AF (2014) Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models. MELANOMA RESEARCH, 24 (2). 108- 119. ISSN 0960-8931 https://doi.org/10.1097/CMR.0000000000000046
SGUL Authors: Bennett, Dorothy Catherine Sviderskaya, Elena Vladimirovna

[img]
Preview
["document_typename_application/pdf; charset=binary" not defined] Published Version
Available under License St George's repository terms & conditions.

Download (1MB) | Preview

Abstract

Melanomas are highly lethal skin tumours that are frequently treated by surgical resection. However, the efficacy of such procedures is often limited by tumour recurrence and metastasis. Caveolin-1 (CAV1) has been attributed roles as a tumour suppressor, although in late-stage tumours, its presence is associated with enhanced metastasis. The expression of this protein in human melanoma development and particularly how the presence of CAV1 affects metastasis after surgery has not been defined. CAV1 expression in human melanocytes and melanomas increases with disease progression and is highest in metastatic melanomas. The effect of increased CAV1 expression can then be evaluated using B16F10 murine melanoma cells injected into syngenic immunocompetent C57BL/6 mice or human A375 melanoma cells injected into immunodeficient B6Rag1−/− mice. Augmented CAV1 expression suppresses tumour formation upon a subcutaneous injection, but enhances lung metastasis of cells injected into the tail vein in both models. A procedure was initially developed using B16F10 melanoma cells in C57BL/6 mice to mimic better the situation in patients undergoing surgery. Subcutaneous tumours of a defined size were removed surgically and local tumour recurrence and lung metastasis were evaluated after another 14 days. In this postsurgery setting, CAV1 presence in B16F10 melanomas favoured metastasis to the lung, although tumour suppression at the initial site was still evident. Similar results were obtained when evaluating A375 cells in B6Rag1−/− mice. These results implicate CAV1 expression in melanomas as a marker of poor prognosis for patients undergoing surgery as CAV1 expression promotes experimental lung metastasis in two different preclinical models.

Item Type: Article
Additional Information: This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/3.0/.
Keywords: Science & Technology, Life Sciences & Biomedicine, Oncology, Dermatology, Medicine, Research & Experimental, Research & Experimental Medicine, DERMATOLOGY, MEDICINE, RESEARCH & EXPERIMENTAL, ONCOLOGY, caveolin-1, syngenic immunocompetent C57BL/6, immunodeficient B6Rag1-/-, surgical resection, promoter of metastasis, PROSTATE-CANCER, SECRETED CAVEOLIN-1, LIPID RAFTS, E-CADHERIN, CELL-LINE, OVEREXPRESSION, SUPPRESSION, SURVIVAL, Oncology & Carcinogenesis, 1103 Clinical Sciences, Science & Technology, Life Sciences & Biomedicine, Oncology, Dermatology, Medicine, Research & Experimental, Research & Experimental Medicine, DERMATOLOGY, MEDICINE, RESEARCH & EXPERIMENTAL, ONCOLOGY, caveolin-1, syngenic immunocompetent C57BL/6, immunodeficient B6Rag1-/-, surgical resection, promoter of metastasis
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Cell Sciences (INCCCS)
Journal or Publication Title: MELANOMA RESEARCH
ISSN: 0960-8931
Related URLs:
Dates:
DateEvent
1 April 2014Published
Web of Science ID: WOS:000332601400003
URI: https://openaccess.sgul.ac.uk/id/eprint/107124
Publisher's version: https://doi.org/10.1097/CMR.0000000000000046

Actions (login required)

Edit Item Edit Item